New Breast Cancer Treatment Option for Patients with HER2 Breast Cancer - CONNECT with VOA

Dr. Nina Balanchivadze, an oncologist at Virginia Oncology Associates who specializes in breast cancer, discusses major developments in treatment for patients with advanced HER2 breast cancer. The American Society of Clinical Oncology (ASCO) held their annual conference where cancer researchers share ground-breaking science. This year's conference presented the results of a breast cancer clinical trial called DESTINY-Breast04 that has made an impact in the treatment of HER2 diseases. The dedicated team of breast cancer doctors at Virginia Oncology Associates offers patients in Hampton Roads and Eastern North Carolina with a multidisciplinary approach to cancer care and the latest treatment options, including clinical trials.